Disclosures for " Feasibility Assessment of Facilitated Subcutaneous Immunoglobulin 1.0 G/Kg with Abbreviated Dose Ramp-Up and without Ramp-Up: A Phase 1 Tolerability and Safety Study in Healthy Adults ")
-
Zhaoyang Li has received personal compensation for serving as an employee of Takeda.
-
Andras Nagy has nothing to disclose.
-
Mr. Khaskhely has nothing to disclose.
-
Mr. Lindner has received personal compensation for serving as an employee of Takeda. Mr. Lindner has stock in Takeda.
-
Kimberly Duff has nothing to disclose.
-
Dr. Garcia has received personal compensation for serving as an employee of Takeda Pharmaceutical Company Limited. Dr. Garcia has stock in Takeda Pharmaceutical Company Limited.
-
Dr. AY has received personal compensation for serving as an employee of Takeda.
-
Dr. Rondon has nothing to disclose.
-
Prof. Yel has received personal compensation for serving as an employee of Takeda. Prof. Yel has stock in Takeda. Prof. Yel has received publishing royalties from a publication relating to health care.